Showing results (31-40 of 608) with videos related to
Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 13, 2025
Early comorbidities and diagnostic challenges in people with multiple sclerosis with possible impact on disease managementChristine Makarov, Ewan Donnachie, Alexander Hapfelmeier, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 28, 2024
Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosisLaura Saucier, Brian C Healy, Shrishti Saxena, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 9, 2024
Disseminated histoplasmosis mimicking post-vaccination side effects in an immunocompromised person with multiple sclerosisAhmad A Toubasi, Steven Allon, Francesca BagnatoMultiple Sclerosis Journal - Experimental, Translational and Clinical|December 26, 2022
Personality traits are not associated with changes in employment status over 3 years in persons with multiple sclerosisK van der Hiele, Eea van Egmond, Dam van Gorp, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 1, 2022
Profiles of resilience in multiple sclerosis family care-partners: A Canadian cross-sectional studyKatherine Cardwell, Odessa McKenna, Jason Steffener, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 15, 2022
Assessing care-related regret among nurses specialized in multiple sclerosis: A psychometric analysis of a new assessment batteryJavier Ballesteros, Guillermo Bueno-Gil, Alfredo Rodríguez-Antigüedad, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosisGabriel Bsteh, Klaus Berek, Harald Hegen, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 15, 2019
Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantationLaura E Baldassari, Sarah M Planchon, Robert A Bermel, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 18, 2018
CorrigendumMultiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2019
Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing SchemeG Giovannoni, P A Brex, D Dhiraj, et al.Pageof 61